Current price is more than the intrinsic value

Intrinsic value

Stock has not been able to generate better return on equity than bank FD

ROE vs FD rates

Stock doesn't offer attractive dividend returns

Dividend Returns

Good time to consider, as stock is not in overbought zone

Entry point

Stock not in ASM/GSM lists and not a lot of promoter holding is pledged

No Red Flags

Vaishali Pharma, Cubex Tubings, YES Bank, Punjab Sind Bank and Crown Lifters, hit their fresh 52-week highs during the day.

Stock market update: Stocks that hit 52-week highs on NSE in today’s trade

Vaishali Pharma standalone net profit rises 42.14% in the September 2022 quarter

Under the pact, Vaishali Pharma to undertake marketing of Sankalp’s nutraceutical productsCompany to make nutraceutical products with focus on gummies, effervescent tablets and capsules

Sankalp Life Care ropes in Vaishali Pharma to market nutraceutical products

Vaishali Pharma Standalone December 2021 Net Sales At Rs 22.28 Crore, Up 4.63% Y-o-Y

Vaishali Pharma standalone net profit declines 6.40% in the December 2021 quarter

Vaishali Pharma standalone net profit rises 81.82% in the September 2021 quarter

Vaishali Pharma reports standalone net profit of Rs 0.81 crore in the June 2021 quarter

Dewansh Vasani successfully handled the trading of API’s in the domestic market and maintaining customer relations.

Vaishali Pharma board to revise Dewansh Vasani’s position to Executive Director

The company has supplied many of its registered products to various countries, and has received very good response for its quality, timely delivery of the products and services.

Vaishali Pharma bags order from Nicaragua and Madagascar for supply of its antibiotics

Vaishali Pharma has predominantly built a portfolio into Veterinary products apart from the range of other products in every segment.

Vaishali Pharma bags supply orders over $100,000 from Russia

Currently, the Company has launched its Immunity booster products in different countries.

Vaishali Pharma stock jumps 6% after launching Immunity booster products

Vaishali Pharma Limited is a pharmaceutical company engaged in dealing in pharmaceutical formulations, active pharmaceutical ingredient (APIs), surgical products, veterinary supplements, and herbal and nutraceutical products

Vaishali Pharma Ltd

Vaishali Pharma Ltd

Intrinsic value
Intrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

ROE vs FD rates
Fixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's long term average ROE is lower than this rate, investors are better off investing the amount in a FD

Dividend Returns
A dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry point
High demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock

News & Opinions

Stock market update: Stocks that hit 52-week highs on NSE in today’s trade

Vaishali Pharma standalone net profit rises 42.14% in the September 2022 quarter

Sankalp Life Care ropes in Vaishali Pharma to market nutraceutical products

Vaishali Pharma Standalone December 2021 Net Sales At Rs 22.28 Crore, Up 4.63% Y-o-Y

Vaishali Pharma standalone net profit declines 6.40% in the December 2021 quarter

Vaishali Pharma standalone net profit rises 81.82% in the September 2021 quarter

Vaishali Pharma reports standalone net profit of Rs 0.81 crore in the June 2021 quarter

Vaishali Pharma Ltd

Intrinsic valueIntrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

ROE vs FD ratesFixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's long term average ROE is lower than this rate, investors are better off investing the amount in a FD

Dividend ReturnsA dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry pointHigh demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock

News & Opinions

Stock market update: Stocks that hit 52-week highs on NSE in today’s trade

Vaishali Pharma standalone net profit rises 42.14% in the September 2022 quarter

Sankalp Life Care ropes in Vaishali Pharma to market nutraceutical products

Vaishali Pharma Standalone December 2021 Net Sales At Rs 22.28 Crore, Up 4.63% Y-o-Y

Vaishali Pharma standalone net profit declines 6.40% in the December 2021 quarter

Vaishali Pharma standalone net profit rises 81.82% in the September 2021 quarter

Vaishali Pharma reports standalone net profit of Rs 0.81 crore in the June 2021 quarter

Intrinsic value
Intrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

ROE vs FD rates
Fixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's long term average ROE is lower than this rate, investors are better off investing the amount in a FD

Dividend Returns
A dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry point
High demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock